---
title: Gadolinium in Medical Imaging - Usefulness, Toxic Reactions and Possible Countermeasures
  - A Review
type: pub
encoding: UTF-8

---
<h1>Publikasjon</h1>
<article id="csl-bib-container-2P7CP7C7" class="csl-bib-container">
  <div class="csl-bib-body"> <div class="csl-entry">Blomqvist, L., Nordberg, G. F., Nurchi, V. M., &#38; Aaseth, J. (2022). Gadolinium in Medical Imaging - Usefulness, Toxic Reactions and Possible Countermeasures - A Review. <i>Biomolecules</i>, <i>12</i>(6). <a href="https://doi.org/10.3390/biom12060742">https://doi.org/10.3390/biom12060742</a></div> </div>
  <div class="csl-bib-buttons">
    <a href="#taxonomy-article-2P7CP7C7" alt="archive" class="csl-bib-button">Arkiv</a>
    <a href="https://app.cristin.no/results/show.jsf?id=2047295" alt="Cristin" class="csl-bib-button">Cristin</a>
    <a href="http://zotero.org/groups/5881554/items/2P7CP7C7" alt="Zotero" class="csl-bib-button">Zotero</a>
    <a href="#keywords-article-2P7CP7C7" alt="keywords" class="csl-bib-button">Emneord</a>
    <a href="#about-article-2P7CP7C7" alt="about_pub" class="csl-bib-button">Om</a>
    <a href="#sdg-article-2P7CP7C7" alt="sdg" class="csl-bib-button">Berekraftsmål</a>
    <a href="https://www.mdpi.com/2218-273X/12/6/742/pdf?version=1653444003" alt="Unpaywall" class="csl-bib-button">Unpaywall</a>
    <a href="https://www.mdpi.com/2218-273X/12/6/742/pdf?version=1653444003" alt="EZproxy" class="csl-bib-button">EZproxy</a>
  </div>
  <div id="csl-bib-meta-container-2P7CP7C7"></div>
</article>
<div id="csl-bib-meta-2P7CP7C7" class="csl-bib-meta">
  <article id="about-article-2P7CP7C7" class="about_pub-article">
    <h1>Om</h1>
    Blomqvist et al. har gjennomgått bruken av gadolinium (Gd), eit sjeldan jordelement, i medisinsk avbilding. Gadolinium blir brukt i kontrastmiddel for MR-skanningar for å hjelpe legar med å sjå inne i kroppen meir tydeleg. Dei fann at Gd kan vere skadelig, spesielt for pasientar med alvorlege nyreproblem, og kan føre til ein alvorleg tilstand kalla nephrogen systemisk fibrose. Denne tilstanden kan vere invalidiserande eller til og med dødeleg. Ved å avgrense bruken av Gd hos desse pasientane, har førekomsten av denne sjukdomen gått ned. Forfattarane merka også at Gd kan bli verande i kroppen sjølv hos pasientar utan nyreproblem, med mengda og typen Gd som påverkar kor mykje som blir verande. Denne gjennomgangen understrekar viktigheita av å forstå eigenskapane, risikoane og bivirkningane til Gd for å betre pasienttryggleiken.
  </article>
  <article id="keywords-article-2P7CP7C7" class="keywords-article">
    <h1>Emneord</h1>
    Gadolinium, Medisinsk avbilding, Toksiske reaksjonar, Nephrogen systemisk fibrose, Gadolinium chelater, Gadolinium toksisitet
  </article>
  <article id="abstract-article-2P7CP7C7" class="abstract-article">
    <h1>Samandrag</h1>
    Gadolinium (Gd) is one of the rare-earth elements. The properties of its trivalent cation (Gd3+) make it suitable to serve as the central ion in chelates administered intravenously to patients as a contrast agent in magnetic resonance imaging. Such Gd-chelates have been used for more than thirty years. During the past decades, knowledge has increased about potential harmful effects of Gd-chelates in patients with severe renal dysfunction. In such patients, there is a risk for a potentially disabling and lethal disease, nephrogenic systemic fibrosis. Restricting the use of Gd-chelates in persons with severely impaired renal function has decreased the occurrence of this toxic effect in the last decade. There has also been an increasing awareness of Gd-retention in the body, even in patients without renal dysfunction. The cumulative number of doses given, and the chemical structure of the chelate given, are factors of importance for retention in tissues. This review describes the chemical properties of Gd and its medically used chelates, as well as its toxicity and potential side effects related to injection of Gd-chelates. 
 
Keywords: chelates; contrast induced nephropathy; gadolinium; gadolinium induced respiratory distress syndrome; gadolinium kinetics; gadolinium toxicity; nephrogenic systemic fibrosis; side effects of gadolinium chelates; treatment of gadolinium toxicity. 
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. 
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/ 
4.0/).
  </article>
  <article id="sdg-article-2P7CP7C7" class="sdg-article">
    <h1>Berekraftsmål</h1>
    <div class="sdg-container"><div id="sdg3" class="sdg">
        <img src="{{< params subfolder >}}images/sdg/sdg03_nn.png" class="image" alt="SDG 3">
        <div class="sdg-overlay">
          <a href="/nn/archive/?key=?sdg=3#archive" class="sdg-publication-count"><span>1358</span> publikasjonar</a>
          <p><a href="https://fn.no/om-fn/fns-baerekraftsmaal/god-helse-og-livskvalitet?lang=nno-NO" class="sdg-read-more">Les meir</a></p>
        </div>
      </div></div>
  </article>
  <article id="taxonomy-article-2P7CP7C7" class="taxonomy-article">
    <h1>Arkiv</h1>
    <ul>
      <li>
        <a href="/nn/archive/?key=3DCRN523">Universitetet i Innlandet</a>
      </li>
      <li>
        <a href="/nn/archive/?key=IDKFS3MX">Fakultet for helse- og sosialvitenskap</a>
      </li>
      <li>
        <a href="/nn/archive/?key=GTV4ECMZ">Institutt for helse- og sykepleievitenskap</a>
      </li>
      <li>
        <a href="/nn/archive/?key=558P36BB">2022</a>
      </li>
      <li>
        <a href="/nn/archive/?key=64A352PX">August</a>
      </li>
    </ul>
  </article>
</div>
